The pharmacokinetics of perindopril in patients with liver cirrhosis - Wikidata - wikimedia - TriplyDB

The pharmacokinetics of perindopril in patients with liver cirrhosis

The pharmacokinetics of perindopril in patients with liver cirrhosis

http://www.wikidata.org/entity/Q34402845

about

Perspectives on Transdermal Electroporation Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.The role of human carboxylesterases in drug metabolism: have we overlooked their importance?Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin.Perindopril for the treatment of hypertension.Transdermal iontophoretic drug delivery: advances and challenges.Prodrugs for transdermal drug delivery - trends and challenges.Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.Decreased carboxylesterases expression and hydrolytic activity in type 2 diabetic mice through Akt/mTOR/HIF-1α/Stra13 pathway.

P2860

Q26752994-247CE68E-E425-4120-BEBA-A02E530BB22C Q36050466-8E415A17-C8B9-4979-A817-ED37D076C6E1 Q36066647-FD436FEA-57D5-4BD6-843F-E4C44AF94E0C Q37163881-F061D138-C989-4BB5-8F46-B03358FF284B Q37877722-23778449-CCB0-42BF-93BC-F93754BC5940 Q38592757-9D2F0491-E472-41B2-B48C-00ED3D92A56E Q38733942-0EDFFB06-0B36-4538-84AD-6DBEFBAF43FB Q51485283-8257B815-69A9-4BBB-9A5A-6E3099DBA78F Q54282765-212B2566-01BD-48A6-8D69-D8E00BF9CA8F

P2860

The pharmacokinetics of perindopril in patients with liver cirrhosis

http://www.wikidata.org/entity/Q34402845

description

1992 nî lūn-bûn

@nan

1992 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի մարտին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

The pharmacokinetics of perindopril in patients with liver cirrhosis

@ast

The pharmacokinetics of perindopril in patients with liver cirrhosis

@en

The pharmacokinetics of perindopril in patients with liver cirrhosis

@nl

type

label

The pharmacokinetics of perindopril in patients with liver cirrhosis

@ast

The pharmacokinetics of perindopril in patients with liver cirrhosis

@en

The pharmacokinetics of perindopril in patients with liver cirrhosis

@nl

prefLabel

The pharmacokinetics of perindopril in patients with liver cirrhosis

@ast

The pharmacokinetics of perindopril in patients with liver cirrhosis

@en

The pharmacokinetics of perindopril in patients with liver cirrhosis

@nl

P1433

Q34402845-6DDE566A-05B2-4169-8250-7B74416A0824

P1476

Q34402845-807E96D2-3DA4-4A3B-BC81-DFA07E573716

P2093

Q34402845-3921181E-3A55-475C-A65E-FBED942FCD2A

Q34402845-502DE8AF-A044-41BF-8023-10A354564AA7

Q34402845-59597566-66CE-41E8-9E22-B183E88354CA

Q34402845-C3EF9FB0-8A5B-4DEE-B14D-696892A472EE

Q34402845-D9515F41-C17C-437E-8AD9-01D611237390

P2860

Q34402845-123D5C84-A415-483F-ADA0-F9D7D9169E43

Q34402845-1DCE0765-555A-44B4-8FDE-73785DC6BECB

Q34402845-5C813F3F-71FD-4A19-8676-7291AE2F2540

Q34402845-7A117841-435B-4A32-BC97-725620FD160A

Q34402845-C4635B03-227B-459F-970E-D20C2AB6943E

Q34402845-DA29C929-87C5-40F9-8D22-A5CF96DA6CD8

Q34402845-EBFF8357-36E9-455B-ABB0-399F778B7643

P304

Q34402845-FE2D6BFE-2D25-460D-AB97-8DDACD775347

P31

Q34402845-63D16D1F-4176-4983-BA01-550F5B3DBA0A

P356

Q34402845-9D635289-8D2D-4FD8-9DB3-131603666616

P407

Q34402845-E88B655F-9ED9-4635-B0C9-F52144980A3A

P433

Q34402845-47C65C6B-EDFB-474C-9190-35D24E64BF60

P478

Q34402845-F21DCC3D-7046-47C2-B165-6BD4AD45DF47

P50

Q34402845-8D015553-72A6-4EE2-BDBF-2F057CC7B4B1

P577

Q34402845-D9C4A7DC-85E2-4D61-B6C2-F5524D8AB5AD

P5875

Q34402845-4B5E0075-D403-4697-B6FF-EF7D2A0FFAD7

P698

Q34402845-AA857136-89E9-477D-875D-0D8008A941B2

P921

Q34402845-B6B22700-2D42-4198-9ABB-C266D8D2A663

P932

Q34402845-AB1C7B1A-534D-41EB-B79F-4685535BC063

P356

J.1365-2125.1992.TB04045.X

P1433

British Journal of Clinical Pharmacology

P1476

The pharmacokinetics of perindopril in patients with liver cirrhosis

@en

P2093

G Resplandy

http://www.w3.org/2001/XMLSchema#string

J D Grangé

http://www.w3.org/2001/XMLSchema#string

M Midavaine

http://www.w3.org/2001/XMLSchema#string

M Thiollet

http://www.w3.org/2001/XMLSchema#string

P Jaillon

http://www.w3.org/2001/XMLSchema#string

P2860

A simple radioassay for angiotensin-converting enzyme

The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis.

The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.

Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man.

Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum.

Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.

Perindopril, converting enzyme blockade, and peripheral arterial hemodynamics in the healthy volunteer.

P304

326-328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.1992.TB04045.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Christian Funck-Brentano

P577

1992-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21579787

http://www.w3.org/2001/XMLSchema#string

P698

1576057

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

1381285

http://www.w3.org/2001/XMLSchema#string